Your browser doesn't support javascript.
loading
Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascularization.
Heid, Irina; Trajkovic-Arsic, Marija; Lohöfer, Fabian; Kaissis, Georgios; Harder, Felix N; Mayer, Moritz; Topping, Geoffrey J; Jungmann, Friderike; Crone, Barbara; Wildgruber, Moritz; Karst, Uwe; Liotta, Lucia; Algül, Hana; Yen, Hsi-Yu; Steiger, Katja; Weichert, Wilko; Siveke, Jens T; Makowski, Marcus R; Braren, Rickmer F.
Afiliação
  • Heid I; School of Medicine, Institute of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany. Irina.Heid@tum.de.
  • Trajkovic-Arsic M; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany.
  • Lohöfer F; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Kaissis G; School of Medicine, Institute of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany.
  • Harder FN; School of Medicine, Institute of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany.
  • Mayer M; Department of Computing, Imperial College London, London, SW7 2AZ, UK.
  • Topping GJ; School of Medicine, Institute for Artificial Intelligence in Medicine and Healthcare, Technical University of Munich, Munich, Germany.
  • Jungmann F; School of Medicine, Institute of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany.
  • Crone B; School of Medicine, Institute of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany.
  • Wildgruber M; School of Medicine, Department of Nuclear Medicine, Technical University of Munich, Munich, Germany.
  • Karst U; School of Medicine, Institute of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany.
  • Liotta L; Institute of Inorganic and Analytical Chemistry, University of Muenster, Muenster, Germany.
  • Algül H; Institute of Clinical Radiology, University Hospital Muenster, Muenster, Germany.
  • Yen HY; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
  • Steiger K; Institute of Inorganic and Analytical Chemistry, University of Muenster, Muenster, Germany.
  • Weichert W; School of Medicine, Clinic and Policlinic of Internal Medicine II, Technical University of Munich, Munich, Germany.
  • Siveke JT; Comprehensive Cancer Center Munich at the Klinikum rechts der Isar (CCCMTUM), Technical University of Munich, Munich, Germany.
  • Makowski MR; School of Medicine, Institute of Pathology, Technical University of Munich, Munich, Germany.
  • Braren RF; School of Medicine, Institute of Pathology, Technical University of Munich, Munich, Germany.
Eur J Nucl Med Mol Imaging ; 50(1): 115-129, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36074156
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Idioma: En Ano de publicação: 2022 Tipo de documento: Article